Form 4: Medtronic Director Lidia Fonseca Reports Stock Transactions

Director Lidia Fonseca reports acquisition and disposal of Medtronic plc ordinary shares.

Summary

• On April 28, 2025, Lidia Fonseca acquired 2,083 ordinary shares at $84.04 and disposed of 216 shares at $84.6 on April 29, 2025.
• Following these transactions, Fonseca directly owns 5,675 ordinary shares.
• The acquisition was due to an award of restricted stock units vesting on the one-year anniversary of the award date.
• 216 shares were withheld for payment of taxes upon the vesting of restricted stock units previously reported.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment as it reports routine stock transactions by a company director. There are no indications of significant positive or negative events.

Positives

• The acquisition of shares indicates a continued investment in the company by a director.

Negatives

• The disposal of shares, while for tax obligations, could be perceived negatively, although it's a common practice.

Industry Context

This is a routine disclosure related to insider trading regulations and is common for publicly traded companies like Medtronic. It provides transparency into the transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers in publicly traded companies, such as Medtronic, to report changes in their beneficial ownership of the company's securities.
• Similar filings are made by executives at comparable companies like Johnson & Johnson and Abbott Laboratories.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of the company, but are unlikely to be significant.

Key Dates

Keywords

Medtronic, Director, Stock Transactions, Form 4, Ordinary Shares, Beneficial Ownership, Lidia Fonseca